# FDGal PET/CT to Detect Hepatocellular Carcinoma

> **NCT02899325** · — · WITHDRAWN · sponsor: **British Columbia Cancer Agency**

## Conditions studied

- Hepatocellular Carcinoma
- Liver Cirrhosis
- Chronic Liver Disease

## Interventions

- **DRUG:** Diagnostic PET/CT scans

## Key facts

- **NCT ID:** NCT02899325
- **Lead sponsor:** British Columbia Cancer Agency
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-10
- **Primary completion:** 2020-10
- **Final completion:** 2021-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PIs will not pursue trial due to staff and time constraints
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02899325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02899325, "FDGal PET/CT to Detect Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02899325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*